Literature DB >> 31103960

Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.

Daniel Savitt1, Joseph Jankovic2.   

Abstract

OBJECTIVE: To describe the phenotype of individuals with intermediate allele (IA) CAG repeat length in the huntingtin (HTT) gene evaluated at the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC) at Baylor College of Medicine (BCM).
BACKGROUND: Huntington disease (HD) is caused by a mutation in the HTT gene of 36 or more CAG trinucleotide repeats. Since our original case report of pathologically proven HD with 29 CAG repeats, a growing body of evidence has accumulated supporting the observation that individuals with IA (27 to 35 CAG repeats) may exhibit clinical, imaging, and pathologic manifestations of HD. About 6% of the general population has CAG repeats in the IA range in at least one allele of the HTT gene. The presence of IA is a challenge for genetic counseling.
METHODS: Medical records of patients with IAs seen at the PDCMDC at BCM from January 2008 to the present were reviewed to assess age at symptom onset, dominant clinical features and presence of psychiatric and cognitive symptoms.
RESULTS: Four men and five women were found to have IAs (range: 27-35) in the course of their evaluation at the PDCMDC. The age at onset of clinically evident symptoms ranged from 27 to 78 years. Six individuals had chorea, three had gait disturbance, two had stereotypies, and one patient had multiple motor tics. All nine had psychiatric symptoms, with depression being the most common.
CONCLUSION: Our series of 9 individuals with IA in the HTT gene exhibit a variety of motor and non-motor features that overlap with the HD phenotype. These individuals and their offspring should be considered at risk for development of progressive HD.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  CAG; Huntington's; Intermediate

Year:  2019        PMID: 31103960     DOI: 10.1016/j.jns.2019.05.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Comment on Clinical Profile of Genetically Proven Huntington's Disease Patients From Eastern India.

Authors:  Gustavo L Franklin; Carlos Henrique Camargo; Alex T Meira; Hélio A G Teive
Journal:  Ann Indian Acad Neurol       Date:  2020-06-24       Impact factor: 1.383

2.  Late-onset Huntington's disease associated with CAG repeat lengths of 30 and 31.

Authors:  Thomas B Stoker; Simon T Holden; Roger A Barker
Journal:  J Neurol       Date:  2021-06-17       Impact factor: 4.849

3.  Incidence of Huntington disease in a northeastern Spanish region: a 13-year retrospective study at tertiary care centre.

Authors:  Paula Sienes Bailo; Raquel Lahoz; Juan Pelegrín Sánchez Marín; Silvia Izquierdo Álvarez
Journal:  BMC Med Genet       Date:  2020-11-23       Impact factor: 2.103

4.  Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients.

Authors:  Assunta Ingannato; Silvia Bagnoli; Salvatore Mazzeo; Valentina Bessi; Sabrina Matà; Monica Del Mastio; Gemma Lombardi; Camilla Ferrari; Sandro Sorbi; Benedetta Nacmias
Journal:  Front Neurosci       Date:  2021-09-03       Impact factor: 4.677

5.  High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.

Authors:  Jimmy Sundblom; Valter Niemelä; Maria Ghazarian; Ann-Sofi Strand; Ingvar A Bergdahl; Jan-Håkan Jansson; Stefan Söderberg; Eva-Lena Stattin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.996

6.  Parkinsonism with a Hint of Huntington's from 29 CAG Repeats in HTT.

Authors:  Sipilä Jot
Journal:  Brain Sci       Date:  2019-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.